Ellen Hoffing - Perrigo Company Independent Director

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:3em;padding-top: 35px;;'>PRG</div>
PRGO -- USA Stock  

Last Earning Anouncement Date: December 31, 2015  

  Director
Ms. Ellen Randi Hoffing is an Independent Director of the Company. Ms. Hoffing served as Chief Operating Officer and CoPresident of Neos Therapeutics, a privately held specialty pharmaceutical company that focuses on extended release liquid and orally disintegrating tablet drug development from September 2009 until April 2014. From 2006 until September 2009, she served as President and Chief Executive Officer of Applied NeuroSolutions, Inc., a development stage biopharmaceutical company focused on diagnostics and therapeutics for the treatment of Alzheimers disease. She has also served as Chairman of Applied NeuroSolutions Board of Directors from 2007 to January 2011 and served as a director since 2006
Age: 57  Director Since 2008      
353 1 709 4000  http://www.perrigo.com
Hoffing?s extensive experience in the pharmaceutical industry includes senior positions at American Pharmaceutical Partners, in 2005, Baxter Healthcare, from 2002 to 2005, and G.D. Searle, from 1983 to 2000.

Management Efficiency

The company has return on total asset (ROA) of 2.19 % which means that it generated profit of $2.19 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 4.32 % meaning that it created $4.32 on every $100 dollars invested by stockholders.
The company currently holds 3.5 B in liabilities with Debt to Equity (D/E) ratio of 60.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 2.03 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Hans HaslerDr Reddys Laboratories Ltd
2016
William SteereZoetis
2013
Michael TrimbleOrigin Agritech Limited
2006
Omkar GoswamiDr Reddys Laboratories Ltd
2000
Willie ReedZoetis
2014
Shikha SharmaDr Reddys Laboratories Ltd
2019
Leo PuriDr Reddys Laboratories Ltd
2018
Gregory NordenZoetis
2013
Anupam PuriDr Reddys Laboratories Ltd
2002
Bruce CarterDr Reddys Laboratories Ltd
2008
Prasad MenonDr Reddys Laboratories Ltd
2019
Charles BakerRegeneron Pharmaceuticals
N/A
Kalpana MorpariaDr Reddys Laboratories Ltd
2007
James KangOrigin Agritech Limited
2010
Yingqi XiaOrigin Agritech Limited
2010
Larry CordellOrigin Agritech Limited
2012
George SingRegeneron Pharmaceuticals
1988
Linda RhodesZoetis
2017
Yuchun LeeVertex Pharmaceuticals Incorpor
2012
Frank DAmelioZoetis
2016
Margaret McGlynnVertex Pharmaceuticals Incorpor
2011

Entity Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company Plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, President
Gary Cohen, Independent Director
Arthur Shannon, IR Contact Officer
Ronald Winowiecki, Acting CFO
Svend Andersen, Executive Vice President and President - Consumer Healthcare International
Judy Brown, CFO and Executive VP
Laurie Brlas, Independent Director
Donal OConnor, Independent Director
James Michaud, Chief Human Resource Officer, Executive Vice President
Louis Yu, Executive Vice President - Global Quality
John Wesolowski, Executive Vice President and Presidentident - RX
Theodore Samuelsto, Independent Director
Scott Jamison, Executive Vice President General Manager - Nutritionals
Ellen Hoffing, Independent Director
Marc Coucke, Executive Vice President General Manager - Omega Pharma Business
Adriana Karaboutis, Independent Director
Michael Jandernoa, Independent Director
Paul Weninger, Executive Vice President - Global Quality Operations
Thomas Farrington, Senior Vice President CIO
Herman Morris, Independent Director
Jeffrey Needham, Executive Vice President General Manager - Consumer Healthcare
Todd Kingma, Executive VP, General Counsel and Secretary
Rolf Classon, Independent Director
Raymond Silcock, CFO
Shlomo Yanai, Independent Director Nominee
Jatin Shah, Senior Vice President Chief Scientific Officer
Michael Stewart, Senior Vice President - Global Human Resources
Jeffrey Kindler, Independent Director
Jacqualyn Fouse, Independent Director
Grainne Quinn, Executive Vice President Chief Medical Officer
Theodore Samuels, Independent Director
Geoffrey Parker, Independent Director
Murray Kessler, President CEO, Director
Sharon Kochan, Executive VP and General Manager of International
Gary Kunkle, Lead Independent Director
Joseph Papa, Chairman and CEO
Marry Brlas, Independent Chairman of the Board
Bradley Alford, Independent Director
Jeffrey Smith, Independent Director
Bradley Joseph, IR Contact Officer
James Dillard, Executive Vice President Chief Scientific Officer
Douglas Boothe, Executive Vice President General Manager - Rx Pharmaceuticals
Ronald Janish, Executive Vice President - Global Operations and Supply Chain
Uwe Rohrhoff, President CEO, Director

Stock Performance Indicators

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Currently Active Assets on Macroaxis

C   
Purchased over 30 shares of
few hours ago
Traded for 80.1
F   
Purchased over 300 shares of
few hours ago
Traded for 9.16
CRSP   
Purchased over 50 shares of
few hours ago
Traded for 58.39
GM   
Purchased over 70 shares of
few hours ago
Traded for 34.91
S   
Purchased over 500 shares of
few hours ago
Traded for 5.02
Please also check Your Equity Center. Please also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.